Azole Resistance in Aspergillus fumigatus: Can We Retain the Clinical Use of Mold-Active Antifungal Azoles?

February 25, 2016 at 7:51 am

Clinical Infectious Diseases February 1, 2016 V.62 N.3 P.362-368

Paul E. Verweij, Anuradha Chowdhary, Willem J. G. Melchers, and Jacques F. Meis

1Department of Medical Microbiology, Radboud University Medical Centre, Nijmegen, The Netherlands

2Department of Medical Mycology, Vallabhbhai Patel Chest Institute, University of Delhi, India

3Department of Medical Microbiology and Infectious Diseases, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands

Azole resistance in Aspergillus fumigatus has now been reported from 6 continents and is emerging as a global health problem.

The epidemiology, spread of azole resistance, the clinical implications, and directions of research are highlighted.

abstract

http://cid.oxfordjournals.org/content/62/3/362.abstract

PDF

http://cid.oxfordjournals.org/content/62/3/362.full.pdf

Advertisements

Entry filed under: Antimicoticos, Epidemiología, Infecciones micoticas, Update.

All-Cause Mortality and Progression Risks to Hepatic Decompensation and Hepatocellular Carcinoma in Patients Infected With Hepatitis C Virus Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America


Calendar

February 2016
M T W T F S S
« Jan   Mar »
1234567
891011121314
15161718192021
22232425262728
29  

Most Recent Posts


%d bloggers like this: